{"id":752906,"date":"2023-05-01T07:36:15","date_gmt":"2023-05-01T11:36:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/"},"modified":"2023-05-01T07:36:15","modified_gmt":"2023-05-01T11:36:15","slug":"werewolf-therapeutics-to-participate-in-may-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/","title":{"rendered":"Werewolf Therapeutics to Participate in May Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., May  01, 2023  (GLOBE NEWSWIRE) &#8212; Werewolf Therapeutics, Inc. (the \u201cCompany\u201d or \u201cWerewolf\u201d) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body\u2019s immune system for the treatment of cancer, today announced that management will participate at the following conferences in the month of May:<\/p>\n<p>\n        <strong>Bank of America 2023 Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Date\/Time: <\/strong>Thursday, May 11 at 1:00 pm ET<br \/><strong>Location:<\/strong> Virtual<br \/><em>Management will participate in a fireside chat.<\/em><\/p>\n<p>\n        <strong>RBC Capital Markets Global Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Date\/Time: <\/strong>Wednesday, May 17 at 11:00 am ET<br \/><strong>Location: <\/strong>Virtual<br \/><em>Management will participate in a fireside chat.<\/em><\/p>\n<p>Live webcast links for the fireside chats will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Sq0P_8VTsItyTwuwPGdfcfOBeQPofahYj7RxtAuQlcW7bCVjGBhICIr4jkVuOC3jIBGGeLMWKXE38hqjsl1tgtN7jgDHlaTb2cerssUdib1tz5lz6IFu3MEV3CeIgnrvVl9YHkdGQM9b271nawAIR1VXB-vA9q5AbxKvyv4g27hVHm7_IydpxXuo9nnML3ii\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.werewolftx.com\/news-and-events\/events<\/a>. An archived replay will be available for approximately 90 days following each presentation.<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>Werewolf<\/strong><br \/>\n        <strong>Therapeutics:<\/strong><br \/>\n        <br \/>Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body\u2019s immune system for the treatment of cancer. We are leveraging our proprietary PREDATOR\u2122 platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Our INDUKINE\u2122 molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules, respectively, for the treatment of solid tumors. We expect to advance clinical studies for WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor and WTX-330 in multiple tumor types or Non-Hodgkin Lymphoma as a single agent. To learn more visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-GRlscAvJjq1vJf-Ru3wdSu1cf-xLQjCNHfYMIwt1q9Uv2r0gLdjqcyDmP6Unnd459VFEjEOEGYfAYhDr5_7gusD-Rhubuuk8oQ4sULJUww=\" rel=\"nofollow noopener\" target=\"_blank\">www.werewolftx.com<\/a>.<\/p>\n<p>\n        <strong>Investor<\/strong><br \/>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Josh Rappaport <br \/>Stern IR <br \/>212.362.1200<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zirtQuXixvHHZB0Y2GplxbUxZc3SF_OwglZCnBFVh8VzInxMCMhvbG5RMiV94Pz0aMAlU2NBUf51nlnMG40hovuluoYUhNtggmjVlXauO-vp1KIisifIrsKJUH-uSWHaQLxbEiw_5J_XKCIeyU9j4rHrVeg4UMoNIbZO8mhrRWdS9O72YYuq9fVLXPz7UQQ8pwyPKCnyFU4M1DWCKNJ2XoXIvA-861qN8bq9OY9xVhSvEOIPrEmlQTOWzomptOx9DillyuQT1YDGV8eSz3mSb6iXy85esxVpjE_NUsHnCHg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Josh.Rappaport@sternir.com<\/u><\/a><\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Peg Rusconi<br \/>VERGE Scientific Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V97pMNGLTRFiOq6loFn5n_UYElxAyf7iYHNiz_ljPPicQd_uQHTtM33j4DN8mjOHo-_jcVN3psD4YnHbAOlS8CyMZcUxX8eaDitAVUtOWZz8VQxS4w68xvMBGGeEG5AG\" rel=\"nofollow noopener\" target=\"_blank\"><u>prusconi@vergescientific.com<\/u><\/a><\/p>\n<p>\n        <strong>Company<\/strong><br \/>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Ellen Lubman<br \/>Chief Business Officer <br \/>Werewolf Therapeutics <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3rJ2iArTJ_j2BDjk4_VMMlWyl9tQTEbmE29DXKWtPb_WC1IqeXsbR657yNthfdzNXC5cxnydlfA6ZdBGbkUajEfAIfbKQ2ehiGzWp3tr3JBxQS5ZytAwm_il8zuybxM4wAueoHalkViNJwwKFW9KjgeB0SYPA823WfJSNu-udQWoMlWSSkjlbJJTmMDsqM_PNZTOOywzNEck4eJnhL_ss0jgiRiQb6os9J_amm6FJhJfzap6EavFQ6rJEXh08cINs0_bC7NcEGifn3hqSGvWQA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>elubman@werewolftx.com<\/u><\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTFiNzM4MjYtOTdmMS00NGU5LWEzZjgtMDg3NDdmODk4NjVjLTEyMTkzMDA=\/tiny\/Werewolf-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Werewolf Therapeutics, Inc. (the \u201cCompany\u201d or \u201cWerewolf\u201d) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body\u2019s immune system for the treatment of cancer, today announced that management will participate at the following conferences in the month of May: Bank of America 2023 Healthcare Conference Date\/Time: Thursday, May 11 at 1:00 pm ETLocation: VirtualManagement will participate in a fireside chat. RBC Capital Markets Global Healthcare Conference Date\/Time: Wednesday, May 17 at 11:00 am ETLocation: VirtualManagement will participate in a fireside chat. Live webcast links for the fireside chats will be available at https:\/\/investors.werewolftx.com\/news-and-events\/events. An archived replay will be available for approximately 90 days following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Werewolf Therapeutics to Participate in May Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752906","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Werewolf Therapeutics, Inc. (the \u201cCompany\u201d or \u201cWerewolf\u201d) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body\u2019s immune system for the treatment of cancer, today announced that management will participate at the following conferences in the month of May: Bank of America 2023 Healthcare Conference Date\/Time: Thursday, May 11 at 1:00 pm ETLocation: VirtualManagement will participate in a fireside chat. RBC Capital Markets Global Healthcare Conference Date\/Time: Wednesday, May 17 at 11:00 am ETLocation: VirtualManagement will participate in a fireside chat. Live webcast links for the fireside chats will be available at https:\/\/investors.werewolftx.com\/news-and-events\/events. An archived replay will be available for approximately 90 days following &hellip; Continue reading &quot;Werewolf Therapeutics to Participate in May Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T11:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Werewolf Therapeutics to Participate in May Investor Conferences\",\"datePublished\":\"2023-05-01T11:36:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/\"},\"wordCount\":313,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/\",\"name\":\"Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\",\"datePublished\":\"2023-05-01T11:36:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/werewolf-therapeutics-to-participate-in-may-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Werewolf Therapeutics to Participate in May Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., May 01, 2023 (GLOBE NEWSWIRE) &#8212; Werewolf Therapeutics, Inc. (the \u201cCompany\u201d or \u201cWerewolf\u201d) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body\u2019s immune system for the treatment of cancer, today announced that management will participate at the following conferences in the month of May: Bank of America 2023 Healthcare Conference Date\/Time: Thursday, May 11 at 1:00 pm ETLocation: VirtualManagement will participate in a fireside chat. RBC Capital Markets Global Healthcare Conference Date\/Time: Wednesday, May 17 at 11:00 am ETLocation: VirtualManagement will participate in a fireside chat. Live webcast links for the fireside chats will be available at https:\/\/investors.werewolftx.com\/news-and-events\/events. An archived replay will be available for approximately 90 days following &hellip; Continue reading \"Werewolf Therapeutics to Participate in May Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T11:36:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Werewolf Therapeutics to Participate in May Investor Conferences","datePublished":"2023-05-01T11:36:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/"},"wordCount":313,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/","name":"Werewolf Therapeutics to Participate in May Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=","datePublished":"2023-05-01T11:36:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODczNyM1NTY2MjExIzIyMDc3NDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/werewolf-therapeutics-to-participate-in-may-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Werewolf Therapeutics to Participate in May Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752906"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}